reglab/statecodes huggingface dataset:
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-26 - "Disease intervention specialist" or "DIS" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 26.
"Disease intervention specialist" or "DIS" means an
				  individual authorized by the department's division of HIV/STD, STD prevention
				  program, trained by the Centers for Disease Control and Prevention to
				  investigate cases of gonorrhea, chlamydia, syphilis, and HIV in an effort to
				  intervene on disease transmission, elicit partners, and complete partner
				  notifications. These individuals work under the authority of the department's
				  division of HIV/STD, STD prevention program. Only state authorized DIS are
				  permitted to investigate HIV and syphilis cases. This definition applies to all
				  state authorized DIS regardless of funding source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-27 - "Disinfect" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 27.
"Disinfect" means the use of directly applied chemical or
				  physical means, or other appropriate processes to destroy or inactivate
				  communicable disease causing agents on inanimate objects.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-28 - "Droplet precautions" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 28.
"Droplet precautions" means safeguards intended to prevent
				  droplet transmission of infectious agents. Droplet transmission involves
				  contact of the conjunctivae or the mucous membranes of the nose or mouth of a
				  susceptible person with large-particle droplets (larger than five (5)
				  micrometers in size) containing microorganisms generated from a person
				  who:
(1) has a clinical disease;
				or
(2) is a carrier of the
				microorganism.
For a complete description, see Guideline for Isolation
				  Precautions: Preventing Transmission of Infectious Agents in Healthcare
				  Settings 2007.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-29 - "Expedited partner therapy" or "EPT" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 29.
"Expedited partner therapy" or "EPT" means the practice of
				  treating sexual partners of patients diagnosed with a sexually transmitted
				  disease (specifically chlamydia or gonorrhea, or both) without an intervening
				  medical evaluation. EPT is a treatment option to increase the likelihood that
				  sex partners get needed medication thus reducing the risk of reinfection and
				  potential further dissemination of these diseases within the community.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-30 - "Food employee" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 30.
"Food employee" means an individual who works with
				  unpackaged food, food equipment or utensils, or food contact surfaces.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-31 - "Food establishment" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC
				  16-18-2-137;
				  IC 16-41-2
Sec. 31.
"Food establishment" has the meaning set forth in IC
				  16-18-2-137.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-32 - "Hand washing procedures" defined

Current through July 10, 2024
Authority: IC 16-19-3-4; IC 16-41-2-1
Affected: IC 16-41-2
Sec. 32.
"Hand washing procedures" means vigorous washing of hands
				  for at least fifteen (15) seconds using soap and running water from an approved
				  water supply, followed by rinsing of hands under water and drying hands using
				  clean paper or single use cloth toweling or air drying devices. Alcohol-based
				  hand sanitizers may be used in accordance with manufacturer's guidelines when
				  hands are not visibly soiled. For hand washing requirements for food employees,
				  see
				  410
				  IAC 7-24. For all others, see Guideline for Hand
				  Hygiene in Health-Care Settings, Morbidity and Mortality Weekly Report, October
				  25, 2002, Volume 51, No. RR-16 and World Health Organization (WHO) Guidelines
				  on Hand Hygiene in Health Care, WHO Press: Geneva, Switzerland, 2009.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-33 - "HAV" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 33.
"HAV" means hepatitis A virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-34 - "HBV" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 34.
"HBV" means hepatitis B virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-35 - "HCV" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 35.
"HCV" means hepatitis C virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-36 - "Health care facility" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 12-25; IC 16-21-2; IC 16-28; IC 16-41-2
Sec. 36.
"Health care facility" includes the following:
(1) Hospitals licensed under IC
				16-21-2.
(2) Private mental health
				institutions licensed under IC 12-25.
(3) Health facilities licensed under IC
				16-28.
(4) Rehabilitation
				facilities.
(5) End stage
				renal/dialysis centers.
(6) Any
				institution, building, or agency or portion thereof, whether public or private
				where:
(A) nursing, rehabilitative, or
				preventive care;
(B)
				treatment;
(C) service;
				or
(D) procedure; to maintain,
				diagnose, or treat an individual's physical or mental condition is provided.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-37 - "Health care worker" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 37.
"Health care worker" means a person who provides care,
				  services, treatment, or procedures, whether as:
(1) a staff member;
(2) a volunteer; or
(3) a student; at a health care facility or
				as an employee of a health care facility.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-38 - "Health practitioner" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 38.
"Health practitioner" means a physician licensed to practice
				  medicine, or if allowed by law, a nurse practitioner, physician assistant, or
				  similar medical professional.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-39 - "HEV" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 39.
"HEV" means hepatitis E virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-40 - "Highly susceptible population" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 40.
"Highly susceptible population" means persons who are more
				  likely than other people in the general population to experience foodborne
				  disease because they are as follows:
(1) Immunocompromised; preschool age children
				or older adults.
(2) Obtaining food
				at a facility that provides services such as custodial care, health care, or
				assisted living, such as a child or adult daycare center, kidney dialysis
				center, hospital or nursing home, or nutritional or socialization services such
				as a senior center.
(3) Children
				nine (9) years of age or younger in a school or custodial child care facility
				that are served juice.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-41 - "HIV" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 41.
"HIV" means human immunodeficiency virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-42 - "HIV infection/disease" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 42.
"HIV infection/disease" means a condition that meets the
				  criteria of one (1) of the following:
(1) Persons who meet the Centers for Disease
				Control and Prevention (CDC) Revised Definition for HIV Infection, as found in
				Morbidity and Mortality Weekly Report, Volume 63, Recommendations and Reports
				No. RR-03, April 11, 2014.
(2)
				Persons who have serologic evidence of HIV infection.
(3) Other persons with signs or symptoms, or
				both, that cause the attending physician to strongly suspect HIV
				infection.
(4) Infants:
(A) born to mothers with HIV
				infection/disease; and
(B) who have
				not been determined to be a seroreverter as defined in the CDC Morbidity and
				Mortality Weekly Report Volume 63, No. RR-03, April 11, 2014.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-43 - "Infant" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 43.
"Infant" means a child less than eighteen (18) months of
				  age.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-44 - "Influenza-associated death" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 44.
"Influenza-associated death" means a human death in which an
				  influenza diagnosis has been detected by one (1) or more of the following
				  methods:
(1) Commercial rapid antigen
				testing.
(2) Viral
				culture.
(3) Direct fluorescent
				antibody (DFA).
(4) Indirect
				fluorescent antibody (IFA).
(5)
				Enzyme immunoassay.
(6) Reverse
				transcription polymerase chain reaction (RT-PCR).
(7) Immunohistochemistry (IHC).
(8) Listed anywhere on the death certificate
				as primary, secondary, or contributory cause of death.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-45 - "Interferon gamma release assay" or "IGRA" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 45.
"Interferon gamma release assay" or "IGRA" means a test that
				  detects the presence of Mycobacterium tuberculosis infection by measuring the
				  immune response to the tuberculosis organism in whole blood.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-46 - "Invasive disease" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 46.
"Invasive disease" means disease:
(1) in association with positive bacterial
				cultures from:
(A) blood;
(B) cerebrospinal fluid;
(C) pleural fluid;
(D) pericardial fluid;
(E) synovial fluid; or
(F) any other usually sterile site;
				or
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-47 - "Isolation" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 47.
"Isolation" means physical separation from others, during
				  the period of communicability, of persons or animals infected or suspected to
				  be infected with a communicable disease to prevent or limit the direct or
				  indirect transmission of infectious agents to uninfected persons.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-48 - "Latent tuberculosis infection" or "LTBI" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 48.
"Latent tuberculosis infection" or "LTBI" means the
				  following:
(1) No symptoms or physical
				findings suggestive of tuberculosis disease.
(2) Mantoux tuberculin skin test (TST) or
				interferon gamma release assay (IGRA) result usually positive.
(3) Chest radiograph typically
				normal.
(4) If done, respiratory
				specimens are smear and culture negative.
(5) Cannot spread tuberculosis bacteria to
				others.
(6) Should consider
				treatment for LTBI to prevent tuberculosis disease.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-49 - "Local health officer" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 49.
"Local health officer" means the county/city health officer
				  or authorized officers, employees, or agents of the county/city health
				  department.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-50 - "Mantoux tuberculin skin test" or "TST" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 50.
"Mantoux tuberculin skin test" or "TST" means a skin test
				  used to detect tuberculosis infection that is performed by injecting purified
				  protein derivative (PPD) intradermally and measuring the reaction (induration
				  or the palpable hardened area) in forty-eight (48) to seventy-two (72) hours
				  after the injection. It is classified as positive or negative depending on the
				  size of the induration and the patient's risk factors for tuberculosis.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-51 - "Medical laboratory" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1;
				  IC
				  16-41-12-17
Affected: IC 16-41-2; IC 16-41-12
Sec. 51.
"Medical laboratory" means an entity that engages in
				  the:
(1) biological;
(2) microbiological;
(3) serological;
(4) chemical;
(5) immunohematological;
(6) radioimmunological;
(7) hematological;
(8) cytological;
(9) pathological; or
(10) other; examination of materials derived
				from the human body for the detection, diagnosis, prevention, or treatment of
				any disease, infection, or impairment, or the assessment of human health. The
				term includes blood centers.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-52 - "Multiple drug-resistant tuberculosis" or "MDR tuberculosis" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 52.
"Multiple drug-resistant tuberculosis" or "MDR tuberculosis"
				  means any tuberculosis infection or disease caused by a strain of Mycobacterium
				  tuberculosis that is resistant to at least isoniazid and rifampin, the two (2)
				  first-line tuberculosis drugs with greatest efficacy.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-53 - "Other potentially infectious materials" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 53.
"Other potentially infectious materials" means the
				  following:
(1) Human body fluids as
				follows:
(A) Semen.
(B) Vaginal secretions.
(C) Cerebrospinal fluid.
(D) Synovial fluid.
(E) Pleural fluid.
(F) Pericardial fluid.
(G) Peritoneal fluid.
(H) Amniotic fluid.
(I) Saliva in dental procedures.
(J) Any body fluid that is visibly
				contaminated with blood.
(K) All
				body fluids where it is difficult or impossible to differentiate between body
				fluids.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-54 - "Outbreak" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 54.
"Outbreak" means cases of disease occurring in a defined
				  community, region, or particular population at a rate in excess of that which
				  is normally expected.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-55 - "Partner services" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 55.
"Partner services" means clinical and epidemiological
				  activities to follow-up with partners who are at risk. Partner services are
				  offered to individuals who are infected with HIV or other STDs, to their
				  partners, and to other persons who are at increased risk for infection in an
				  effort to prevent transmission of these diseases and to reduce suffering from
				  their complications. Services include:
(1) identifying partners and obtaining
				partner locating information providing information regarding current infection
				or infections, HIV, and other STDs;
(2) ensuring confidential notification,
				appropriate medical attention, and appropriate social referrals for partners
				and other high-risk individuals;
(3) using client-centered counseling to
				develop risk reduction plans to reduce the likelihood of acquiring future STDs
				(including HIV);
(4) providing
				needed referrals to additional medical or social services; and
(5) defining and better targeting the at-risk
				community while ensuring complete confidentiality for the patient.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-56 - "Person in charge" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 56.
"Person in charge" means the individual present in a food
				  establishment who is responsible for the operation at the time of inspection.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-57 - "Postsecondary facility" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 57.
"Postsecondary facility" means a location (public or
				  private) that provides education beyond the secondary (grade 12) level. This
				  includes, but is not limited to:
(1)
				colleges;
(2)
				universities;
(3) vocational
				schools; or
(4) technical
				schools.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-58 - "Preschool" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 58.
"Preschool" means a school or other institution for children
				  who are not eligible to enter kindergarten in a public, nonpublic, or charter
				  school.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-59 - "Prophylaxis" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 59.
"Prophylaxis" means treatment or therapy intended to prevent
				  infection of an individual who may have been or could be exposed to a
				  communicable disease.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-60 - "Quarantine" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 60.
"Quarantine" means the restriction of activities or
				  confinement of well persons or animals who have, or may have been exposed to a
				  case of communicable disease during its period of communicability to prevent
				  disease transmission during the incubation period, if infection should occur.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-61 - "Ready-to-eat food" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 61.
(a)
				"Ready-to-eat food" means food that:
(1) is in
				a form that is edible without additional preparation to achieve food
				safety;
(2) is a raw or partially
				cooked animal food and the consumer is advised;
(3) is prepared in accordance with a variance
				that is granted; or
(4) may receive
				additional preparation for palatability or aesthetic, epicurean, gastronomic,
				or culinary purposes.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-62 - "Regulatory authority" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 62.
"Regulatory authority" means the local, state, or federal
				  enforcement body or authorized representative having jurisdiction over the food
				  establishment.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-63 - "Residential institution" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 63.
"Residential institution" means any facility where residents
				  live in group settings. This includes, but is not limited to:
(1) homeless shelters;
(2) group homes;
(3) residential K-12 schools; or
(4) dormitories, residence halls, or other
				campus housing.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-64 - "Restrict" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 64.
"Restrict" means to limit the activities of a food employee
				  so that there is no risk of transmitting a disease that is transmissible
				  through food and the food employee does not work with exposed food, clean
				  equipment, utensils, linens, or unwrapped single-service or single-use
				  articles.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-65 - "Restriction of activities" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 65.
"Restriction of activities" means limitations placed on the
				  activities of persons to prevent transmission of communicable diseases to other
				  individuals. Limitations may include, but are not limited to, restrictions on
				  one (1) or more of the following activities:
(1) Attendance/appearance at any:
(A) school;
(B) preschool; or
(C) daycare facility.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-66 - "Sexually transmitted disease" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 66.
"Sexually transmitted disease" means local or systemic
				  communicable diseases due to infectious agents, generally transmitted
				  person-to-person by sexual intercourse or genital mucosal contact, including,
				  but not limited to, the following:
(1)
				HIV.
(2) HBV.
(3) HCV.
(4) Gonorrhea.
(5) Chlamydia.
(6) Syphilis.
(7) Chancroid.
(8) Granuloma inguinale.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-67 - "Standard precautions" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 67.
"Standard precautions" means safeguards used for all
				  patients receiving care in health care facilities, regardless of diagnosis, or
				  suspected or confirmed infection status, to prevent transmission of
				  microorganisms from both recognized and unrecognized sources of infection.
				  Requirements of standard precautions are presented in Guideline for Isolation
				  Precautions: Preventing Transmission of Infectious Agents in Healthcare
				  Settings 2007.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-68 - "State designated districts" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 68.
"State designated districts" means those local health
				  departments or clinics that have been designated as "authorized agents" by the
				  department's division of HIV/STD.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-69 - "Sterile site" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 69.
"Sterile site" means the following:
(1) Blood.
(2) Cerebral spinal fluid (CSF).
(3) Pleural fluid (includes chest fluid,
				thoracentesis fluid).
(4)
				Peritoneal fluid (includes abdominal fluid, ascites).
(5) Pericardial fluid.
(6) Bone (includes bone marrow).
(7) Joint (includes synovial fluid; fluid,
				needle aspirate, or culture of any specific joint: knee, ankle, elbow, hip,
				wrist).
(8) Internal body sites
				(specimen obtained from surgery or aspirate from one (1) of the following:
				lymph node, brain, heart, liver, spleen, vitreous fluid, kidney, pancreas, or
				ovary).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-70 - "Sterilize" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 70.
"Sterilize" means the use of physical or chemical
				  procedures, or other appropriate processes to destroy all microbial life,
				  including highly resistant bacterial endospores.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-71 - "Suspect case" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 71.
"Suspect case" means a person, living or deceased, whose
				  medical history, signs, symptoms, or laboratory evidence suggests that this
				  person may be:
(1) incubating;
				or
(2) actively infected with; a
				communicable disease.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-72 - "Terminal cleaning" defined

Current through July 10, 2024
Authority: IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 72.
"Terminal cleaning" means standardized cleaning to remove
				  dust, soil, and microbial contamination on inanimate surfaces and is done after
				  a patient has been removed by death or transfer, or has ceased to be a source
				  of infection, or after isolation or other practices/precautions have been
				  discontinued.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-73 - "Tuberculosis disease" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2
Sec. 73.
"Tuberculosis disease" means disease in a person with
				  tuberculosis infection in whom symptoms, signs, or radiographic manifestations
				  caused by Mycobacterium tuberculosis are apparent. Disease may be pulmonary or
				  extrapulmonary, or both.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-74 - "Universal precautions" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 74.
"Universal precautions" means an approach to infection
				  control in which all human blood and other potentially infectious materials are
				  treated as if known to be infectious for:
(1) HIV;
(2) HBV;
(3) HCV; and
(4) other bloodborne pathogens.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-75 - Reporting requirements for physicians and hospital administrators

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC
				  4-22-2-37.1;
				  IC 16-21; IC
				  16-41-2-8;
				  IC 25-22.5
Sec. 75.
(a) It
				shall be the duty of each:
(1) physician
				licensed under IC 25-22.5; and
(2)
				administrator of a hospital licensed under IC 16-21, or the administrator's
				representative; to report all cases and suspected cases of the diseases listed
				in subsection (d). Reporting of specimen results by a laboratory to health
				officials does not nullify the physician's or administrator's obligations to
				report the case.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-76 - Laboratories; reporting requirements

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC
				  16-41-2-8
Sec. 76.
(a) Each
				director, or the director's representative, of a medical laboratory in which
				examination of any specimen derived from the human body yields:
(1) microscopic;
(2) bacteriologic;
(3) immunologic;
(4) serologic; or
(5) other; evidence of infection by any of
				the organisms or agents listed in subsection (d) shall report the findings and
				any other epidemiologically necessary information to the department. HIV
				serologic results of tests performed anonymously in conjunction with the
				operation of a counseling and testing site registered with the department shall
				not be identified by the name of the patient, but by a numeric identifier code.
				For the appropriate method to report the results, see subsection (b).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-77 - Disease intervention measures; responsibility to investigate and implement

Current through July 10, 2024
Authority: IC 16-19-3-4; IC 16-41-2-1
Affected: IC 16-41-2
Sec. 77.
(a) Case
				reports submitted to the local health department or the department may be used
				for:
(1) epidemiological investigation;
				or
(2) other disease intervention
				activities; as warranted. Prior approval from a patient is not required before
				releasing medical or epidemiological information to the local health department
				or the department or state designated districts.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-78 - Confidentiality of medical and epidemiological information

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-18-2; IC 16-41; IC
				  34-43-1-12;
				  IC
				  36-2-14-21
Sec. 78.
(a) All
				information obtained under this rule, whether from patient records or other
				sources, is confidential as specified by IC
				16-41-8-1.
(b) Except as provided in subsection (a), a
				person responsible for recording, reporting, or maintaining information
				required to be reported under IC 16-41-2 who recklessly, knowingly, or
				intentionally discloses or fails to protect medical or epidemiological
				information classified as confidential under this section commits a Class A
				misdemeanor.
(c) In addition to
				subsection (b), a public employee who violates this section is subject to
				discharge or other disciplinary action under the personnel rules of the agency
				that employs the employee.
(d)
				Release shall be made of the medical records concerning an individual to:
(1) the individual;
(2) a person authorized in writing by the
				individual to receive the medical records; or
(3) a coroner under IC
				36-2-14-21.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-79 - General control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 79.
General control measures are as follows:
(1) A local health officer or the
				commissioner, upon being notified of the existence of any communicable disease
				covered by a specific control measure in this section, shall ensure that the
				procedures required under the rule for the specific disease are carried
				out.
(2) A local health officer or
				the commissioner, upon learning or being notified of communicable diseases that
				are not covered by any specific control measures in this section, shall place
				such restrictions upon the movements of cases or carriers and their contacts as
				may be reasonably necessary to prevent the spread of disease. Specific control
				measures for the selected diseases or conditions are listed in sections 80
				through 148 of this rule and are based on best practices outlined in the
				following references:
(A) Red Book: 2012
				Report of the Committee on Infectious Diseases, 29th edition, a publication of
				the American Academy of Pediatrics.
(B) Epidemiology and Prevention of
				Vaccine-Preventable Diseases, 12th Edition, a publication of the Centers for
				Disease Control and Prevention.
(C)
				Manual for the Surveillance of Vaccine-Preventable Diseases, 5th Edition, a
				publication of the Centers for Disease Control and Prevention.
(D) Case Definitions for Infectious
				Conditions Under Public Health Surveillance. Morbidity and Mortality Weekly
				Report; May 2, 1997; Volume 46; No. RR-10.
(E) 2012 Nationally Notifiable Diseases and
				Conditions and Current Case Definitions, a publication of the Centers for
				Disease Control and Prevention.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-80 - Animal bites; specific control measures

Current through July 10, 2024
Authority: IC 16-19-3-4; IC 16-41-2-1
Affected: IC 15-17-6-11; IC 16-41-2; IC 16-41-9
Sec. 80.
(a) The
				specific control measures for animal bites are as follows:
(1) Every case of a human bitten by a
				domestic or wild mammal shall be reported within twenty-four (24) hours to the
				local health officer having jurisdiction. If a physician is in attendance, the
				physician shall report the bite. The report shall include requested information
				on postexposure rabies prophylaxis if it is being administered to the bite
				victim. Each reported bite shall be investigated immediately by the local
				health officer. This investigation shall be conducted with the purpose of
				determining the need for postexposure rabies prophylaxis of the bite victim and
				either:
(A) imposing a ten (10) day
				observation period on the biting animal (dog, cat, or ferret only) to determine
				if the animal was capable of transmitting rabies at the time of the biting
				incident; or
(B) submission of the
				head, if the biting animal is a potential rabies vector, to the department
				laboratory to determine if it was infected with rabies.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-81 - Anthrax; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 81.
The specific control measures for anthrax (infectious agent:
				  Bacillus anthracis) are as follows:
(1) An investigation by the local health
				officer shall be performed immediately to determine the source of exposure.
				History of exposure to animals and animal products (wool, hair, or raw leather)
				and travel to endemic anthrax areas shall be fully investigated.
(2) Standard precautions for isolation of
				hospitalized patients shall be followed.
(3) Discharges from lesions and articles
				contaminated with discharges require disinfection. An infectious agent is a
				spore former that will survive in environment for long periods. Disinfection
				requires sporicidal agent.
(4)
				Quarantine is not necessary.
(5) If
				exposure occurred in an occupational/industrial setting, a review of industrial
				hygiene practices shall be made to reduce the risk of other cases.
(6) The Centers for Disease Control and
				Prevention and the Council of State and Territorial Epidemiologists set the
				standard clinical and laboratory case definition.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-82 - Arboviral disease (non-neuroinvasive and neuroinvasive); specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 82.
The specific control measures for arboviral encephalitis
				  (West Nile virus, La Crosse/California serogroup virus, eastern equine
				  encephalitis, western equine encephalitis, Powassan encephalitis, St. Louis
				  encephalitis, dengue, chikungunya virus, and Japanese encephalitis) are as
				  follows:
(1) An investigation by the
				local health officer shall be performed immediately for the purpose of
				identifying location and presence of vector mosquitoes. If applicable, the
				local health officer shall:
(A) obtain travel
				history prior to illness; and
(B)
				identify traveling companions who may have been exposed.
Active surveillance shall be instituted. The local health
				  officer shall identify areas in the community where there is a need for vector
				  control. Identification of cases in horses, birds, or humans provides evidence
				  of virus presence and amplification in the community environment.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-83 - Babesiosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 83.
The specific control measures for babesiosis (infectious
				  agent: Babesia species) are as follows:
(1) An investigation by the local health
				officer shall:
(A) be performed within
				seventy-two (72) hours; and
(B)
				focus on source of exposure to:
(i) infected
				ticks; or
(ii) recent blood
				transfusions.
Travel history for the previous six (6) months to include the
				  most recent summer months is essential.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-84 - Botulism; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 84.
The specific control measures for botulism - foodborne,
				  infant, wound, or other (infectious agent: Clostridium botulinum), are as
				  follows:
(1) An investigation by the
				local health officer shall meet the following conditions:
(A) Be performed immediately (within three
				(3) hours after clinical suspicion).
(B) Include the following prior to symptom
				onset:
(i) Five (5) day food and drink
				history.
(ii) Fourteen (14) day
				wound history.
(C)
				Recover all suspected food for appropriate testing and disposal.
(D) If suspicion is high that the source is a
				commercial food product or a product served in a restaurant, the local health
				officer shall perform active surveillance to identify additional cases. The
				purpose of the investigation shall be case ascertainment, assurance of
				availability of the appropriate antitoxin through the department, and
				identification of the infection source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-85 - Brucellosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 85.
The specific control measures for brucellosis (infectious
				  agent: Brucella species) are as follows:
(1) An investigation by the local health
				officer shall be performed immediately to trace infection to the common or
				individual source, usually:
(A) infected dogs,
				domestic goats, swine, or cattle;
(B) unpasteurized milk or dairy products
				(cheese) from cows and goats; or
(C) foreign travel.
Occupational exposures from slaughterhouses or others working
				  with infected animal tissues or products should be considered. Animals
				  suspected of being infected shall be managed according to requirements of the
				  Indiana state board of animal health.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-86 - Campylobacteriosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 86.
The specific control measures for Campylobacter enteritis
				  (infectious agent: Campylobacter species) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a five (5) day
				history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Domestic and international
				travel.
(iii) Water
				exposures.
(iv) Animal
				exposures.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) Determine if meal companions are
				additional cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-87 - Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE); specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 87.
(a) The
				specific control measures for carbapenemase-producing carbapenem-resistant
				Enterobacteriaceae (CP-CRE) (infectious agent: organisms that are
				nonsusceptible to at least one (1) carbapenem antibiotic with MIC >=2
				µg/ml or zone diameter <=22 mm (<=21 mm for ertapenem), and meet
				one (1) of the following criteria:
(1)
				Positive for carbapenemase production by a phenotypic test (e.g., Modified
				Hodge or Carba NP).
(2)
				Nonsusceptible to at least three (3) carbapenem antibiotics with MIC >=2
				µg/ml or zone diameter <=22 mm (<=21 mm for ertapenem).
(3) Positive for a carbapenemase gene
				marker.) are listed in subsection (b).
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-88 - Chancroid; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 88.
The specific control measures for chancroid (infectious
				  agent: Haemophilus ducreyi) are as follows:
(1) An investigation by the local health
				officer shall be:
(A) performed within
				seventy-two (72) hours; and
(B)
				focused on identifying sexual partners who were at risk for transmitting to, or
				contracting the infection from, the case.
Case and contacts shall be fully evaluated and treated as
				  recommended in the Sexually Transmitted Diseases Treatment Guidelines, 2010,
				  Morbidity and Mortality Weekly Report, December 17, 2010, Volume 59, No.
				  RR-12.